DIBS - Hot Stocks: TLRY lights up cannabis stocks; PFE BMY LLY hit new highs; DIBS threatens IPO price

PPAMPicture/E+ via Getty Images The Federal Reserve is still battling inflation. Regulators are calling for stronger oversight of Big Tech. Earnings continue to pour in. Who needs to relax? Cannabis bellwether Tilray (TLRY) took that instinct to the bank in the most recent quarter, reporting standout earnings that sparked a massive spike in the company's shares. The advance carried over to the sector in general, with OrganiGram Holdings (OGI), Cronos Group (CRON) and Canopy Growth (CGC) all posting notable advances. Earnings had a positive impact on more traditional drug makers as well. Pfizer (PFE) and Bristol-Myers Squibb (BMY) both set 52-week highs in the wake of their respective quarterly reports. Rival Eli Lilly (LLY) rode their coattails to a new peak as well. Turning away from those established firms to a relative newcomer on Wall Street, 1stDibs.com (DIBS) has had a bumpy ride since coming public a little more than

For further details see:

Hot Stocks: TLRY lights up cannabis stocks; PFE, BMY, LLY hit new highs; DIBS threatens IPO price